Recently, results from Volcano Corporation's (VOLC) PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study were published in The New England Journal of ...

SAN DIEGO, CHRON Volcano Corporation today announced its participation in the Paris course for Revascularization (EuroPCR) from May 17 — 20. Volcano's focus will be on highlighting the strength of its ...

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This ...

Release of these novel precision guidance tools will be demonstrated in live cases, symposia and training programs throughout the week SAN DIEGO, CA -- Volcano Corporation, a leading company focused ...

Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural ...

Volcano Corp. has announced it has received FDA clearance for its new intravascular ultrasound catheter, according to a news release. The Visions PV .035 digital IVUS catheter is designed to image ...

Volcano Corporation VOLC, a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced ...

Enrolling 3,349 patients, the IVUS sub-study is part of the Cardiovascular Research Foundation's (CRF) ADAPT-DES study (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents), a prospective ...

Amsterdam, the Netherlands - Two US companies are sharing the spoils of Amsterdam cardiovascular device company JOMED, declared bankrupt by the Amsterdam district court in early May 2003. Abbott ...

Please provide your email address to receive an email when new articles are posted on . IVUS-guided PCI reduced risk for target vessel failure for patients with ACS vs. angiography-guided PCI. Lower ...